Globeflex Capital’s Globus Medical GMED Stock Holding History

Globeflex Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$474K	Sell	5,998 -200	-3%	-$17K	0.06%	242
2026 Q1	$534K	Buy	6,198 +4,213	+212%	+$378K	0.08%	220
2025 Q4	$173K	Buy	+1,985	New	+$151K	0.03%	319
2016 Q3	–	Sell	-48,594	Closed	-$1.16M	–	505
2016 Q2	$1.16M	Hold	48,594	–	–	0.32%	108
2016 Q1	$1.15M	Hold	48,594	–	–	0.31%	107
2015 Q4	$1.35M	Hold	48,594	–	–	0.36%	71
2015 Q3	$1M	Sell	48,594 -9,592	-16%	-$243K	0.22%	158
2015 Q2	$1.49M	Sell	58,186 -150	-0.3%	-$3.8K	0.27%	108
2015 Q1	$1.47M	Sell	58,336 -214	-0.4%	-$5.21K	0.28%	115
2014 Q4	$1.39M	Hold	58,550	–	–	0.27%	120
2014 Q3	$1.15M	Sell	58,550 -93	-0.2%	-$1.91K	0.13%	187
2014 Q2	$1.4M	Buy	58,643 +13,344	+29%	+$322K	0.15%	167
2014 Q1	$1.2M	Sell	45,299 -11,823	-21%	-$281K	0.14%	185
2013 Q4	$1.15M	Sell	57,122 -122	-0.2%	-$2.27K	0.14%	183
2013 Q3	$999K	Hold	57,244	–	–	0.13%	210
2013 Q2	$965K	Buy	+57,244	New	+$883K	0.13%	199

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Globeflex Capital's GMED Position: Q2 2026 in Review

Globeflex Capital reduced its Globus Medical (GMED) stake by 3.2% in Q2 2026, selling an estimated $17K and leaving 5,998 shares worth $474K. The position accounts for 0.06% of the portfolio, ranked #242.

Globeflex Capital first reported a position in GMED in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.49M in Q2 2015. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Globeflex Capital held 5,998 shares of Globus Medical worth $474K as of Q2 2026.
Globeflex Capital sold 200 Globus Medical shares in Q2 2026, an estimated $17K.
Globus Medical made up 0.06% of Globeflex Capital's portfolio in Q2 2026, its #242 holding.
Globeflex Capital first reported a position in Globus Medical in Q2 2013 and has held it in 16 quarters since.
Globeflex Capital's Globus Medical position peaked at $1.49M in Q2 2015.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.